logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9862944 B1

PDFFull Text
Date of Patent:
Jan. 09, 2018

Filed:

Mar. 14, 2014

Antisense oligonucleotides for treatment of cancer stem cells

Applicant:

Andes Biotechnologies S.a., Ñuñoa, Santiago, CL;

Inventors:

Luis O. Burzio Eriz, Santiago, CL;

Veronica A. Burzio Menendez, Santiago, CL;

Jaime E. Villegas Olavarria, Santiago, CL;

Assignee:

ANDES BIOTECHNOLOGIES S.A., Santiago, CL;

Attorney:

Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.

Primary Examiner:

Amy Bowman

Int. Cl.
CPC ...
A61K 48/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61K 31/7088 (2006.01); A61K 45/06 (2006.01); A61K 31/7105 (2006.01); C12N 5/09 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/7088 (2013.01); A61K 31/7105 (2013.01); A61K 45/06 (2013.01); C12N 5/0693 (2013.01); C12N 2310/113 (2013.01); C12N 2320/30 (2013.01); C12N 2320/31 (2013.01); C12N 2501/65 (2013.01); C12N 2501/999 (2013.01); C12N 2510/00 (2013.01);
Abstract

The invention provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating and preventing metastasis or relapse of a cancer in an individual previously treated for cancer with a therapy. The invention also provides oligonucleotides complementary to a non-coding chimeric mitochondrial RNA as well as compositions and kits comprising the same, and their use in treating a refractory cancer (e.g., a refractory HPV-associated cancer).

Find Patent Forward Citations

Burzio Eriz, Luis. (2018). Antisense oligonucleotides for treatment of cancer stem cells (U.S. Patent No. 9862944). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9862944

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…